Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872721 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 12 Pages |
Abstract
The present results suggest that TC-A and bcl-2 antisense oligonucleotides reduce radioresistance of tumor cells overexpressing Bcl-2. Therefore, a combination of radiotherapy and Bcl-2 inhibitors may prove to be a useful therapeutic approach for treating tumors that overexpress Bcl-2.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Takamitsu M.S., Motoko M.D., Ph.D., Cheng M.D., Yoshihiro M.D., Ph.D., Megumi M.S., Tomio M.D., Ph.D.,